Thursday, March 23, 2017, from 5:15 PM - 6:30 PM
Dr. Michael L. Van Linn will be discussing the trends and challenges of new psychoactive substances (NPS) on the illicit drug market and their impact on public health and safety, and the regulatory response to protect the public. Recent case studies and the scheduling process under the U.S. Controlled Substances Act will also be discussed. Dr. Van Linn is a Drug Science Specialist in the Diversion Control Division of the Drug Enforcement Administration (DEA). Please join us.